Related Experiment Video
Updated: Mar 30, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey
Mathieu Bourdenx1,2, Sandra Dovero1,2, Philippe De Deurwaerdère1,2
1Université De Bordeaux, Institut Des Maladies Neurodégénératives, Bordeaux, UMR 5293, France.
Abstract:
The discovery of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxin that induces parkinsonism in both human and primate, has prompted the search for environmental toxins potentially responsible for idiopathic Parkinson's disease (PD). The present study reports the ultimate effects of MPTP intoxication of a female macaque monkey, which unraveled to be pregnant after parkinsonism had developed, upon its fetus. Detailed examination of the offpsring nigrostriatal pathway showed that tyrosine hydroxylase immunoreactivity in caudate-putamen nuclei and substantia nigra compacta (SNc) was not different from an age-matched control. Biochemical analysis of the tissue content of dopaminergic markers further suggested modification of metabolism in the MPTP-exposed monkey. These data suggest that early prenatal intoxication does not destroy nigrostriatal neurons, most likely because dopamine neurons had not developed yet when exposed to MPTP.
Insights
Prenatal exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) did not damage developing dopamine neurons in a macaque fetus. This suggests early MPTP exposure does not cause Parkinson's disease by destroying these critical neurons.
Area of Science:
- Neuroscience
- Toxicology
- Developmental Biology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes parkinsonism in humans and primates.
- The cause of idiopathic Parkinson's disease (PD) remains largely unknown, prompting research into environmental toxins.
- MPTP's effects on developing nervous systems, particularly during prenatal stages, are not well understood.
Purpose of the Study:
- To investigate the effects of prenatal MPTP exposure on the developing nigrostriatal pathway in a macaque fetus.
- To determine if MPTP-induced parkinsonism in a pregnant macaque affects fetal dopaminergic neuron development.
- To assess potential long-term consequences of early developmental exposure to MPTP.
Main Methods:
- MPTP intoxication was administered to a pregnant macaque monkey.
- Postnatal examination of the offspring's nigrostriatal pathway, including tyrosine hydroxylase (TH) immunoreactivity in the caudate-putamen and substantia nigra compacta (SNc).
- Biochemical analysis of dopaminergic markers in the offspring's brain tissue.
Main Results:
- No significant difference in tyrosine hydroxylase immunoreactivity was observed in the offspring's nigrostriatal pathway compared to controls.
- Biochemical analyses suggested alterations in dopamine metabolism, but not a destruction of dopaminergic neurons.
- The findings indicate that the developing dopamine neurons were likely not yet present or fully formed at the time of MPTP exposure.
Conclusions:
- Early prenatal exposure to MPTP does not appear to destroy nigrostriatal dopaminergic neurons in macaques.
- This lack of destruction is likely due to the developmental stage of dopamine neurons at the time of exposure.
- These findings suggest that MPTP may not be a direct cause of idiopathic Parkinson's disease through prenatal neurodegeneration.

